Advancements in Chronic Kidney Disease Management: Exploring the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Guidelines: Brooklyn Hospital Only
Target Audience
All pharmacists
Learning Objectives
At the completion of this activity, the participant will be able to:
Define chronic kidney disease (CKD) and the clinical consequences of CKD progression.
Identify methods for evaluating and classifying the severity of CKD.
State the Kidney Disease Improving Global Outcomes (KDIGO) recommendations for the pharmacologic prevention of CKD progression.
Recall literature supporting pharmacotherapeutic options to slow or prevent the progression of CKD.
Christopher Donaldson, PharmD
PGY1 Pharmacy Resident, The Brooklyn Hospital Center
Christopher is a graduate of the Medical University of South Carolina and a current resident at The Brooklyn Hospital Center. Upon completion of his PGY1 residency program, Christopher will continue his training in Infectious Disease as a PGY2 resident at The Brooklyn Hospital Center
ACPE UAN 0042-0000-24-029-L01-P
Available Credit
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.